THURSDAY, Nov. 20, 2025 (HealthDay News) -- For adults with venous thromboembolism (VTE), continuing oral anticoagulants (OAC) after initial anticoagulation of
Continuing Oral Anticoagulants After ≥90 Days Tied to Lower Risk for Recurrent VTE
HealthDay1 hrs ago
17


AlterNet
KTRE 9 News
Associated Press US and World News Video
CBS News
Missoula Current
WHAS 11
Reuters US Domestic
Arizona Daily Sun